Brett Hauber

8.3k total citations · 2 hit papers
192 papers, 6.2k citations indexed

About

Brett Hauber is a scholar working on Economics and Econometrics, General Health Professions and Oncology. According to data from OpenAlex, Brett Hauber has authored 192 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Economics and Econometrics, 25 papers in General Health Professions and 21 papers in Oncology. Recurrent topics in Brett Hauber's work include Health Systems, Economic Evaluations, Quality of Life (75 papers), Economic and Environmental Valuation (43 papers) and Statistical Methods in Clinical Trials (19 papers). Brett Hauber is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (75 papers), Economic and Environmental Valuation (43 papers) and Statistical Methods in Clinical Trials (19 papers). Brett Hauber collaborates with scholars based in United States, United Kingdom and Switzerland. Brett Hauber's co-authors include F. Reed Johnson, John F. P. Bridges, Deborah A. Marshall, Josephine Mauskopf, Andrew Lloyd, Lisa A. Prosser, Dean A. Regier, Juan Marcos González, Ateesha F. Mohamed and Karin Groothuis‐Oudshoorn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Brett Hauber

181 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force

2011 1.4k citations John F. P. Bridges, Brett Hauber et al. Value in Health profile →
Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force

2016 898 citations Brett Hauber, Juan Marcos González et al. Value in Health profile →

Peers

Brett Hauber

GHP

PHEOH

ONCOL

PPCH

F. Reed Johnson United States

Louis P. Garrison United States

Anirban Basu United States

Esther W. de Bekker‐Grob Netherlands

Bernie J. OʼBrien Canada

Jeffrey S. Hoch Canada

Su Golder United Kingdom

Katherine Payne United Kingdom

Nick Bansback Canada

Jonathan Karnon Australia

F. Reed Johnson United States

Brett Hauber

4.8k ×1.5

1.7k ×1.3

GHP

824 ×1.3

PHEOH

533 ×0.9

ONCOL

551 ×1.1

PPCH

Citations per year, relative to Brett Hauber Brett Hauber (= 1×) peers F. Reed Johnson

Countries citing papers authored by Brett Hauber

Since Specialization

Citations

This map shows the geographic impact of Brett Hauber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett Hauber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett Hauber more than expected).

Fields of papers citing papers by Brett Hauber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett Hauber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett Hauber. The network helps show where Brett Hauber may publish in the future.

Co-authorship network of co-authors of Brett Hauber

This figure shows the co-authorship network connecting the top 25 collaborators of Brett Hauber. A scholar is included among the top collaborators of Brett Hauber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett Hauber. Brett Hauber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hauber, Brett, et al.. (2025). Patient preferences for long-acting HIV treatment: a preference heterogeneity assessment. BMC Infectious Diseases. 25(1). 237–237.

Veldwijk, Jorien, Semra Özdemir, Juan Marcos González, et al.. (2025). Transferability of Preferences; for Better or ….?. Patient. 18(2). 97–100.

Hauber, Brett, Kathleen Beusterien, Amy Law, et al.. (2024). A latent class analysis of factors influencing preferences for infant respiratory syncytial virus (RSV) preventives among pregnant people in the United States. Human Vaccines & Immunotherapeutics. 20(1). 2358566–2358566. 8 indexed citations

Vietri, Jeffrey, Liping Huang, Vincenza Snow, et al.. (2023). 1740. Healthcare Providers’ Preferences for Pediatric Pneumococcal Vaccination Recommendations in the United States. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Pinto, Cathy Anne, Tommi Tervonen, Cecilia Jimenez‐Moreno, et al.. (2023). Current Practices and Challenges When Submitting Patient Experience Data for Regulatory Decisions by the US Food and Drug Administration: An Industry Survey. Patient. 17(2). 147–159. 4 indexed citations

Bridges, John F. P., Esther W. de Bekker‐Grob, Brett Hauber, et al.. (2023). A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task Force. Value in Health. 26(2). 153–162. 32 indexed citations

Hauber, Brett, et al.. (2023). Priority Outcomes in Sickle Cell Disease Treatment: Co-Creation and Implementation of a Preference Exercise With Patients and Caregivers to Inform Drug Development. Journal of Patient Experience. 10. 672723143–672723143. 2 indexed citations

Tervonen, Tommi, Chiara Whichello, Ernest H. Law, et al.. (2023). Treatment preferences of adults and adolescents with alopecia areata: A discrete choice experiment. The Journal of Dermatology. 51(2). 243–252. 4 indexed citations

Bekker‐Grob, Esther W. de, Juan Marcos González, F. Reed Johnson, et al.. (2022). 13th Meeting of the International Academy of Health Preference Research. Patient. 15(6). 729–738. 1 indexed citations

10.

Simons, Gwenda, Ellen M. Janssen, Jorien Veldwijk, et al.. (2022). Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD Open. 8(2). e002593–e002593. 8 indexed citations

11.

Simons, Gwenda, Jorien Veldwijk, Rachael L. DiSantostefano, et al.. (2022). Preferences for preventive treatments for rheumatoid arthritis: discrete choice survey in the UK, Germany and Romania. Lara D. Veeken. 62(2). 596–605. 10 indexed citations

12.

Watt, Stephen, Ed Whalen, Leo Russo, et al.. (2022). Multimethod quantitative benefit‐risk assessment of treatments for moderate‐to‐severe osteoarthritis. British Journal of Clinical Pharmacology. 88(8). 3837–3846. 4 indexed citations

13.

Falahee, Marie, Gwenda Simons, Rachael L. DiSantostefano, et al.. (2021). Treatment preferences for preventive interventions for rheumatoid arthritis: protocol of a mixed methods case study for the Innovative Medicines Initiative PREFER project. BMJ Open. 11(4). e045851–e045851. 8 indexed citations

14.

Boeri, Marco, et al.. (2019). Patient and physician preferences for ulcerative colitis treatments in the United States. SHILAP Revista de lepidopterología. 2 indexed citations

15.

Boeri, Marco, et al.. (2019). <p>From drug-delivery device to disease management tool: a study of preferences for enhanced features in next-generation self-injection devices</p>. Patient Preference and Adherence. Volume 13. 1093–1110. 12 indexed citations

16.

Ho, Martin, Juan Marcos González, Carolyn Y. Neuland, et al.. (2014). Incorporating patient-preference evidence into regulatory decision making. Surgical Endoscopy. 29(10). 2984–2993. 178 indexed citations

17.

Yuan, Zuyi, et al.. (2013). Relative importance of benefits and risks associated with antithrombotic therapies of acute coronary syndrome: Patient and physician perspectives. Value in Health. 16(3). A292–A293. 2 indexed citations

18.

Groothuis‐Oudshoorn, Karin, et al.. (2012). Integrating patient preferences and clinical trial data in a Bayesian model for benefit-risk assessment. Atherosclerosis. 17(3). 383–8. 1 indexed citations

19.

Mohamed, Ateesha F., F. Reed Johnson, Brett Hauber, Bénédicte Lescrauwaet, & Allan J. Masterson. (2012). Physicians’ stated trade-off preferences for chronic hepatitis B treatment outcomes in Germany, France, Spain, Turkey, and Italy. European Journal of Gastroenterology & Hepatology. 24(4). 1–1. 11 indexed citations

20.

Parsons, George R. & Brett Hauber. (2000). The Effect of Nesting Structure Specification on WelfareEstimation in a Random Utility Model of Recreation Demand: An Application to the Demand for Recreational Fishing. SSRN Electronic Journal. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact